US equity
·Updated Oct 12, 21:38 UTCABT
Abbott Laboratories
Health Care·Large cap·$177B
101.82
+2.2% today
No price history available for this name yet.
Returns & momentum
1D+2.2%
1W+1.7%
1M-0.1%
3M+15.3%
6M+2.5%
1Y-21.9%
YTD—
All-time—
Range & moving averages
Price101.82
52w high-22.5%
52w low+25.1%
All-time high—
All-time low—
% from ATH—
50-day MA—
vs 50-DMA—
200-day MA—
vs 200-DMA—
Liquidity & activity
Volume7.1M
Turnover$728M
Market cap$177B
RVOL0.79×
Risk & valuation
Real. vol 30d—
Real. vol 90d—
Max drawdown—
Beta · SPY—
P/E—
P/B—
ROE—
Div yield—
Financials
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $44.3B | $42.0B | $40.1B | $43.7B | $43.1B | $34.6B | $31.9B | $30.6B | $27.4B | $20.9B | $20.4B | $20.2B | $19.7B | $19.1B | $21.4B | $35.2B |
| Cost of revenue | $19.3B | $18.7B | $18.0B | $19.1B | $18.5B | $15.0B | $13.2B | $12.7B | $12.4B | $9.1B | — | — | — | — | — | — |
| Research & development | $2.9B | $2.8B | $2.7B | $2.9B | $2.7B | $2.4B | $2.4B | $2.3B | $2.3B | — | — | — | — | — | — | — |
| Selling, general & admin | $12.3B | $11.7B | $10.9B | $11.2B | $11.3B | $9.7B | $9.8B | $9.7B | $9.2B | $6.7B | $6.8B | $6.5B | $6.4B | $6.7B | $7.4B | $10.4B |
| Operating income | $8.1B | $6.8B | $6.5B | $8.4B | $8.4B | $5.4B | $4.5B | $3.6B | $1.6B | $3.0B | $2.9B | $2.6B | $2.1B | $1.4B | $1.6B | $6.1B |
| Interest expense | — | — | $637M | $558M | $533M | $546M | $670M | $826M | $904M | $431M | $163M | $150M | $145M | $320M | $359M | $553M |
| Income tax | $1.9B | -$6.4B | $941M | $1.4B | $1.1B | $497M | $390M | $539M | $1.9B | $350M | $577M | $797M | $53M | -$457M | $110M | $1.1B |
| Net income | $6.5B | $13.4B | $5.7B | $6.9B | $7.1B | $4.5B | $3.7B | $2.4B | $477M | $1.4B | $4.4B | $2.3B | $2.6B | $6.0B | $4.7B | — |
| EPS — basic | $3.73 | $7.67 | $3.28 | $3.94 | $3.97 | $2.52 | $2.07 | $1.34 | $0.27 | $0.94 | $2.94 | $1.50 | $1.64 | $3.76 | $3.03 | $2.98 |
| EPS — diluted | $3.72 | $7.64 | $3.26 | $3.91 | $3.94 | $2.50 | $2.06 | $1.33 | $0.27 | $0.94 | $2.92 | $1.49 | $1.62 | $3.72 | $3.01 | $2.96 |
| Shares — basic | 1.74B | 1.74B | 1.74B | 1.75B | 1.78B | 1.77B | 1.77B | 1.76B | 1.74B | 1.48B | 1.5B | 1.52B | 1.56B | 1.58B | 1.56B | 1.55B |
| Shares — diluted | 1.75B | 1.75B | 1.75B | 1.76B | 1.79B | 1.79B | 1.78B | 1.77B | 1.75B | 1.48B | 1.51B | 1.53B | 1.57B | 1.59B | 1.57B | 1.56B |
From SEC filings (public domain), since 2008. Values as reported (USD); per-share figures are per diluted/basic share. Point-in-time — each figure reflects the latest amount filed for that period. Descriptive context only, not advice.
Informational scan, not a buy/sell recommendation or financial advice in any jurisdiction.